insights_auto
Why is ALCOX down २.१०%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€ ०.३०
arrow_downward
-२.१०%(-०.००६५) 1D
अक्टोबर १२, १७:३५:१० GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३०
Mkt. cap
२.९४ करोड
Avg. vol.
१.६५ लाख
Volume
१.१६ लाख
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३०
Mkt. cap
२.९४ करोड
Avg. vol.
१.६५ लाख
Volume
१.१६ लाख
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
News stories
From web sources and news partners
The Business Journals
·
३९ मिनेट पहिले
FirstBank CEO rings NYSE bell a decade after IPO as lender eyes future
CNBC
·
३९ मिनेट पहिले
The bull market turned 4 years old on Monday. Investors say reaching a fifth birthday could be challenging
Yahoo Finance
·
५ घण्टा पहिले
A handful of tech stocks are masking an ugly S&P 500 problem
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees१०
Founded१९९६
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, फ्रान्स
Sector-
Websitenicox.com